会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Pacemaker with vasovagal syncope detection
    • 起搏器与血管迷走性晕厥检测
    • US5441525A
    • 1995-08-15
    • US246903
    • 1994-05-20
    • Michael B. SheltonKenneth M. RiffMichael F. Hess
    • Michael B. SheltonKenneth M. RiffMichael F. Hess
    • A61N1/365A61N1/36
    • A61N1/36514A61N1/365
    • A rate-responsive cardiac pacemaker implements a novel scheme which detects incipient vasovagal syncope (or other episodes caused by a vasodepressive or cardioinhibitory disorder) when a) the heart rate drops below a programmable minimum size, and b) the rate after said drop is below a programmable maximum drop ending rate. The pacemaker implements a stability and intervention procedure upon the detection of an episode, in which it ignores transient drops in rate, and paces at a predetermined high rate if the drops are stable. The pacemaker then gradually reduces the pacing rate over a predetermined time to the pre-episodic level. A sleep disable feature disables the vasovagal syncope detection and therapy features during the patient's sleeping hours to reduce or eliminate false positive responses.
    • 速率响应心脏起搏器实施一种新颖的方案,其检测初期的血管迷走性晕厥(或由血管抑郁或心脏抑制障碍引起的其他发作),当a)心率下降到可编程的最小尺寸以下时,b)所述下降之后的速率低于 可编程的最大下降结束率。 起搏器在检测到发作时实现稳定性和干预程序,其中它忽略了速率的瞬时下降,并且如果液滴是稳定的,起搏器以预定的高速度步进。 然后,起搏器逐渐将起搏速度在预定时间内降低到事件发生前的水平。 睡眠禁用功能在患者睡眠时间内禁用血管迷走性晕厥检测和治疗功能,以减少或消除假阳性反应。
    • 3. 发明授权
    • Clinic based instrument system for remote processing and access to implanted systems information
    • 基于诊所的仪器系统,用于远程处理和获取植入系统信息
    • US08634926B2
    • 2014-01-21
    • US10936153
    • 2004-09-08
    • Michael F. HessChristopher M. Manrodt
    • Michael F. HessChristopher M. Manrodt
    • A61N1/372
    • A61N1/37282A61N1/37247
    • A system for accessing implantable medical device (IMD) data is provided including an interrogation appliance to retrieve data from an IMD and transfer the data to a processor. The processor converts the device data to a viewable form that is transferred by the processor to a data destination. The data destination may be an electronic mail address, a secure web site, a facsimile number or the interrogation appliance. The data is presented in a viewable form at the data destination either on a display or by printing. Any number of interrogation appliances may be communicatively coupled to the processor for converting IMD data and providing the IMD data back to a data destination in a viewable form for use by a clinician.
    • 提供了一种用于访问植入式医疗设备(IMD)数据的系统,其包括用于从IMD检索数据并将数据传送到处理器的询问设备。 处理器将设备数据转换为由处理器传送到数据目的地的可视窗体。 数据目的地可以是电子邮件地址,安全网站,传真号码或询问设备。 在显示器上或通过打印在数据目的地以可视形式呈现数据。 任何数量的询问设备可以通信地耦合到处理器,用于转换IMD数据,并以可视形式将IMD数据提供给数据目的地,供临床医生使用。
    • 5. 发明授权
    • Atrial anti-arrhythmia pacemaker and method using high rate atrial and
backup ventricular pacing
    • 心房抗心律失常起搏器及方法采用高速心房起搏和备用心室起搏
    • US5928271A
    • 1999-07-27
    • US30312
    • 1998-02-25
    • Michael F. HessKathleen A. Prieve
    • Michael F. HessKathleen A. Prieve
    • A61N1/362A61N1/368A61N1/365
    • A61N1/3622
    • An atrial and ventricular pacemaker including an atrial pulse generator having the capability of delivering high rate atrial pacing pulses for electrophysiologic study and having the capability of delivering ventricular pacing pulses as a backup, during delivery of high rate atrial pacing pulses. Delivery of backup ventricular pacing pulses may be preconditioned upon the occurrence of a desired number, proportion or pattern of occurrences of paced ventricular beats preceding delivery of high rate atrial pacing pulses. Timing of ventricular backup pulses is synchronized to delivered atrial pacing pulses which occur closely timed to expiration of a defined ventricular escape interval for backup pacing. The defined escape interval for ventricular backup pacing may be set as a function of the average interval separating ventricular events preceding initiation of high rate atrial pacing.
    • 一种心房起搏器,包括心房脉搏发生器,其具有递送高速率心房起搏脉搏用于电生理学研究的能力,并且具有在递送高速率心房起搏脉冲期间提供心室起搏脉冲作为备用的能力。 备用心室起搏脉冲的传送可以在出现高速率心房起搏脉冲之前出现所需数量,比例或出现的起搏心室搏动的情况下进行预处理。 心室备用脉冲的定时与递送的心房起搏脉冲同步,其发生紧密定时到定义的心室逃逸间隔到达用于后备起搏。 定义的心室起搏起搏间隔可以设置为在高速率心房起搏开始之前分隔心室事件的平均间隔的函数。
    • 8. 发明授权
    • Delivery of CRT therapy during AT/AF termination
    • 在AT / AF终止期间交付CRT治疗
    • US07953482B2
    • 2011-05-31
    • US12389680
    • 2009-02-20
    • Michael F. Hess
    • Michael F. Hess
    • A61N1/362
    • A61N1/3627A61N1/3622A61N1/3925A61N1/3956A61N1/3962
    • In some embodiments, a method for operating a cardiac rhythm management device may include one or more of the following steps: (a) sensing atrial depolarizations through an implanted atrial electrode, (b) administering a sequential CRT pacing therapy in a sequential CRT pacing mode to a left and right ventricle of a heart of a patient via implanted ventricular electrodes in a sequential bi-ventricular fashion, (c) switching from the sequential CRT pacing mode to a simultaneous CRT pacing mode, (d) administering a simultaneous CRT pacing therapy in the simultaneous CRT pacing mode to the left and right ventricle in a simultaneous bi-ventricular fashion, (e) analyzing the sensed atrial depolarizations to detect the presence of an atrial arrhythmia, (f) analyzing the sensed atrial depolarizations while in the sequential CRT pacing mode to detect the presence of atrial arrhythmia, and (g) sensing ventricular depolarizations of the left and the right ventricle.
    • 在一些实施例中,用于操作心律管理装置的方法可以包括以下步骤中的一个或多个:(a)通过植入的心房电极感测心房去极化,(b)以连续的CRT起搏模式施用连续的CRT起搏治疗 (c)从连续的CRT起搏模式切换到同步的CRT起搏模式,(d)同时进行CRT起搏治疗,其中, (e)分析感测到的心房去极化以检测心房心律失常的存在,(f)分析感染的心房去极化,同时在顺序CRT中 起搏模式来检测心律失常的存在,(g)感测左心室和右心室的心室去极化。
    • 9. 发明授权
    • Automated reapplication of atrial pacing therapies
    • 心房起搏治疗的自动再次应用
    • US06876880B2
    • 2005-04-05
    • US10034060
    • 2001-12-20
    • Michael F. HessRahul MehraEduardo N. WarmanNirav V. ShethMark L. BrownDavid Ritscher
    • Michael F. HessRahul MehraEduardo N. WarmanNirav V. ShethMark L. BrownDavid Ritscher
    • A61N1/365A61N1/362A61N1/39
    • A61N1/3622A61N1/3624
    • The invention relates to the use of atrial pacing therapies to treat atrial tachycardia (AT). When an AT episode is detected, an implantable medical device applies an ATP therapy. If the AT episode persists, the ATP therapy may be automatically reapplied at a later time during the course of the same AT episode. In particular, previously used ATP therapies are reapplied when episodic conditions, such as cycle length or cycle regularity, change. Although a particular ATP therapy initially may be unsuccessful in terminating the AT, it may prove successful when the cycle length or regularity of the atrial rhythm changes. As the rhythm slows down, the AT may be more responsive to ATP therapies that were previously unsuccessful. As a result, potentially efficacious ATP therapies can be reapplied to terminate AT episodes, and reduce the number of episodes that require more aggressive termination by painful, atrial shocks.
    • 本发明涉及心房起搏疗法用于治疗房性心动过速(AT)的用途。 当检测到AT发作时,可植入医疗装置应用ATP疗法。 如果AT发作持续存在,ATP疗法可能会在相同的AT发作过程中的较晚时间自动重新应用。 特别是,当诸如循环长度或循环规律性等情况时,先前使用的ATP疗法将被重新应用。 尽管特定的ATP疗法最初可能不能终止AT,但是当心房节律的周期长度或规律性发生变化时,可能会成功。 随着节奏减慢,AT可能对以前不成功的ATP疗法更有反应。 因此,可以重新应用潜在有效的ATP疗法来终止AT发作,并通过痛苦的心房休克减少需要更积极终止的发作次数。